Theophylline anhydrous - Drug Shortage Information

Public shortage context is available across 3 visible exact NDC pages for this generic drug family.

This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.

Exact NDC product pages in this shortage family

Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.

Drug NameNDC 11ManufacturerShortage Context
theophylline anhydrous 200 mg / 1 Capsule 100 Capsule, Extended Release (Theo-24)
NDC 52244-0200-10 | 100 Capsule, Extended Release | ENDO USA, Inc.
52244-0200-10ENDO USA, Inc.Current shortage context
theophylline anhydrous 400 mg / 1 Capsule 100 Capsule, Extended Release (Theo-24)
NDC 52244-0400-10 | 100 Capsule, Extended Release | ENDO USA, Inc.
52244-0400-10ENDO USA, Inc.Current shortage context
Theophylline, Anhydrous 400 mg / 1 Tablet 100 Tablet, Extended Release
NDC 42858-0701-01 | 100 Tablet, Extended Release | Rhodes Pharmaceuticals L.P.
42858-0701-01Rhodes Pharmaceuticals L.P.Current shortage context

Common brands and presentations in this family

These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.